LU AA 37096Alternative Names: Lu AA37096; LU-AA37096
Latest Information Update: 18 May 2009
At a glance
- Originator Lundbeck A/S
- Class Analgesics; Mood stabilisers
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Mood disorders; Pain
Most Recent Events
- 03 Jan 2008 Phase-I clinical trials in Pain in Denmark (unspecified route)
- 03 Jan 2008 Phase-I clinical trials in Affective disorders in Denmark (unspecified route)